This article is a commentary on:
Transcriptome Analysis of Host Inflammatory Responses to the Ectoparasitic Mite Sarcoptes scabiei var. hominis
Kate E. Mounsey1,2*- 1School of Health, University of the Sunshine Coast, Maroochydore, QLD, Australia
- 2Sunshine Coast Health Institute, Birtinya, QLD, Australia
A Commentary on
Transcriptome analysis of host inflammatory responses to the ectoparasitic mite Sarcoptes scabiei var. hominis
by Shehwana H, Ijaz S, Fatima A, Walton S, Sheikh ZI, Haider W and Naz S (2021) Front. Immunol. 12:778840. doi: 10.3389/fimmu.2021.778840
1 Introduction
Scabies is a highly prevalent infectious disease of underappreciated health burden. In resource poor settings, secondary infections of scabietic lesions are linked to significant sequelae including acute post-streptococcal glomerulonephritis and rheumatic heart disease (1). Crusted scabies, a rare clinical manifestation associated with hyperproliferation of mites, is associated with high mortality if untreated, and sarcoptic mange in animals is a significant health and welfare issue (2). While scabies is readily treatable in individuals, timely diagnosis is confounded due to a lack of sensitive and specific methods. Emerging drug resistance is a concern in some regions (3), and population-level control can be difficult to implement (4).
There are few studies on the immunology of scabies, and those that do exist are mostly based on small case numbers, lack appropriate controls, or focus on a small number of candidate molecules (5). Relative to other parasitic diseases, scabies is especially difficult to study due to the inability to maintain mites in culture, and a historical lack of tractable animal models for in-vivo study (6). Access to infested patients for research can be difficult, especially for more invasive procedures such as skin biopsy collection. This is important, as scabies mites are limited to the host epidermis, and studying localised immune responses in the skin provides rich insight compared to peripheral blood.
In this paper, Shehwana, Ijaz and colleagues describe the first transcriptomic study on scabietic lesions from human patients (n = 5) and healthy controls (n=3). They also conduct a detailed comparative analysis of their results with that of previous studies- including an in-vivo transcriptomic analysis of skin biopsies from infested pigs published by my group (7), and in-vitro mite infested human skin equivalents (8). From this, a clearer and more consistent picture of the immune and inflammatory events associated with scabies begin to emerge. In this commentary, I discuss key themes emerging from this paper, and its contribution to this neglected aspect of parasite immunology.
2 Timing of scabies immune responses
Scabies involves a delayed onset of clinical manifestations, due to modulation of inflammatory responses by mite molecules. The delay is estimated to be four to six weeks in a primary exposure and reduces with repeat infestations- consistent with the acquisition of immunological memory. In the study by Shehwana, Ijaz et al., clinical history of the patients is not provided. Patients are described as “one to two weeks post-exposure”- it is uncertain whether this actually refers to a defined exposure event, or rather the onset of clinical manifestations. If the latter, it is unsurprising that the human transcriptome results aligned best with the porcine samples from week 8 post-infestation. If the former, they could potentially represent a repeat exposure given the rapidity of symptom onset.
In our porcine study we found variation in gene expression profiles between pre-clinical (1-2 weeks), and later (week 8) infestation, with a switch from suppressed to activated inflammatory responses. In the study by Shehwana, Ijaz et al., the authors also observed distinct clustering according to time. This temporality in response is important to consider in the design and interpretation of other studies and especially where diagnostic biomarkers for early diagnosis are evaluated. It may also partially explain areas of discordance between the different datasets. This is most apparent in the gene expression signatures relating to T cell activation and proliferation. In the human samples, downregulation of genes related to immunoglobulin and TCR binding was observed, whereas in the porcine data these genes were downregulated in earlier weeks but upregulated at week 8. This could also be related to clinical severity, as skin T cell proliferation, especially CD8+ and γδ−T cells has been observed in crusted relative to ordinary scabies (9, 10).
3 Key players of scabies-associated skin inflammation
Scabies shares clinical features with aspects of atopic dermatitis and psoriasis- both are common differential diagnoses for scabies. Being an ectoparasite, it also shares immunomodulatory features with other mucosal parasites- in-vitro studies show the inhibition of complement (11) and stimulation of regulatory T cells (12) by mite molecules. However, in-vivo, it was markers of skin inflammation that are most apparent. Clear patterns between the human and porcine datasets were observed, including activation of JAK/STAT inflammatory signaling via IL-19 and IL-20, and T cell chemokine signatures. CXCL8, chemoattractant for neutrophils and a strong stimulator of inflammation was one of the most highly upregulated genes in both datasets. Also highly expressed were the S100 family of antimicrobial peptides, as seen in other proliferative skin disorders. Other upregulated genes linked to a psoriatic gene expression profile included DEFB4A, IL17A, and IL17RB. It is of note that several of these key genes were not seen in the human skin equivalent dataset, reinforcing the importance of in-vivo studies to obtain a comprehensive picture of immune responses for descriptive studies.
4 Molecules associated with clinical severity of scabies
It was of interest to compare and contrast the magnitude of gene expression between ordinary (human) and crusted (porcine) datasets. Crusted scabies was associated with much higher expression of CXCL8, IL-19, IL-20, IL-17A, S100A8 and S100A12. Immunotherapy targeting IL-17A, which has downstream impacts on IL-19 and IL-20 and subsequent keratinocyte proliferation (13, 14) is now widely utilized in psoriasis and may be useful in ameliorating crusted scabies. Highly upregulated genes in the porcine crusted dataset but not the human dataset included arginase 1 and CXCL6. The authors noted AADACL3 downregulation and its previous association with crusted scabies via chromosomal duplication and altered expression (15). This gene was not represented in the porcine dataset and any association should be interpreted with caution given it is only based on one case study with functional links unclear.
5 Reframing old paradigms of scabies immunology
Previous studies on scabies based on measurement of cytokines in peripheral blood stimulated with mite antigens have characterized ordinary scabies as a Th1 response, and crusted scabies as a non-protective, Th2 response (16). A recent meta-analysis (5) describes sarcoptic mange and evidence supporting either Type I or Type IV hypersensitivity, and unfortunately excluded studies on humans and the transcriptomic studies described herein. Such compartmentalization is too generalist. The studies by Shewana, Ijaz et al., and our group has revealed that both ordinary and crusted scabies are associated with Th2 signatures (IL-4 and IL-13), as would be expected from a parasitic infestation, with an increased magnitude of IL-17 pathway related cytokines and effector molecules in crusted scabies (10, 17). As crusted scabies is very commonly associated with extremely high IgE and often eosinophilia (18), but also shows T cell dysregulation in the skin, elements of both Type I and Type IV hypersensitivity are represented.
6 Conclusion
The authors are to be commended on this important study and its contribution to our limited understanding of scabies immunopathology. While much work needs to be done to identify specific deficits and factors impacting clinical severity of scabies, we now have a clearer picture of biological pathways, candidate biomarkers and immunotherapeutic targets for this neglected disease. Future studies focused on crusted scabies in humans, mechanisms of immunomodulation via host-parasite interactions, and time-associated immune profiling would add further contributions. The strong concordance between the human and porcine data attests to the utility of the porcine model to inform elements of human scabies.
Author contributions
The author confirms being the sole contributor of this work and has approved it for publication.
Acknowledgments
I acknowledge the mentorship and contributions to the field by Dr Shelley Cavezza (Walton) and their support in submission of this commentary.
Conflict of interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Welch E, Romani L, Whitfeld MJ. Recent advances in understanding and treating scabies. Fac Rev (2021) 10:28. doi: 10.12703/r/10-28
2. Escobar LE, Carver S, Cross PC, Rossi L, Almberg ES, Yabsley MJ, et al. Sarcoptic mange: An emerging panzootic in wildlife. Transbound Emerg Dis (2022) 69:927–42. doi: 10.1111/tbed.14082
3. Meyersburg D, Kaiser A, Bauer JW. Loss of efficacy of topical 5% permethrin for treating scabies: an Austrian single-center study’. J Dermatolog Treat (2022) 33:774–7. doi: 10.1080/09546634.2020.1774489
4. Lake SJ, Kaldor JM, Hardy M, Engelman D, Steer AC, Romani L. Mass drug administration for the control of scabies: A systematic review and meta-analysis. Clin Infect Dis (2022) 75:959–67. doi: 10.1093/cid/ciac042
5. Næsborg-Nielsen C, Wilkinson V, Mejia-Pacheco N, Carver S. Evidence underscoring immunological and clinical pathological changes associated with sarcoptes scabiei infection: Synthesis and meta-analysis. BMC Infect Dis (2022) 22:658. doi: 10.1186/s12879-022-07635-5
6. Mounsey K, Ho MF, Kelly A, Willis C, Pasay C, Kemp DJ, et al. A tractable experimental model for study of human and animal scabies. PloS Negl Trop Dis (2010) 4:e756. doi: 10.1371/journal.pntd.0000756
7. Bhat SA, Walton SF, Ventura T, Liu X, McCarthy JS, Burgess STG, et al. Early immune suppression leads to uncontrolled mite proliferation and potent host inflammatory responses in a porcine model of crusted versus ordinary scabies. PloS Negl Trop Dis (2020) 14:e0008601. doi: 10.1371/journal.pntd.0008601
8. Morgan MS, Arlian LG, Markey MP. Sarcoptes scabiei mites modulate gene expression in human skin equivalents. PloS One (2013) 8:e71143. doi: 10.1371/journal.pone.0071143
9. Walton SF, Beroukas D, Roberts-Thomson P, Currie BJ. New insights into disease pathogenesis in crusted (Norwegian) scabies: The skin immune response in crusted scabies. Br J Dermatol (2008) 158:1247–55. doi: 10.1111/j.1365-2133.2008.08541.x
10. Liu X, Walton SF, Murray HC, King M, Kelly A, Holt DC, et al. Crusted scabies is associated with increased IL-17 secretion by skin T cells. Parasite Immunol (2014) 36:594–604. doi: 10.1111/pim.12129
11. Swe PM, Reynolds SL, Fischer K. Parasitic scabies mites and associated bacteria joining forces against host complement defence. Parasite Immunol (2014) 36:585–93. doi: 10.1111/pim.12133
12. Arlian LG, Morgan MS, Paul CC. Evidence that scabies mites (Acari: Sarcoptidae) influence production of interleukin-10 and the function of T-regulatory cells (Tr1) in humans. J Med Entomol (2006) 43:283–7. doi: 10.1603/0022-2585(2006)043[0283:etsmas]2.0.co;2
13. Xu X, Prens E, Florencia E, Leenen P, Boon L, Asmawidjaja P, et al. Interleukin-17A drives IL-19 and IL-24 expression in skin stromal cells regulating keratinocyte proliferation. Front Immunol (2021) 12:719562. doi: 10.3389/fimmu.2021.719562
14. Witte E, Kokolakis G, Witte K, Philipp S, Doecke WD, Babel N, et al. IL-19 is a component of the pathogenetic IL-23/IL-17 cascade in psoriasis. J Invest Dermatol (2014) 134:2757–67. doi: 10.1038/jid.2014.308
15. Hatter AD, Soler DC, Curtis C, Cooper KD, McCormick TS. Case report of individual with cutaneous immunodeficiency and novel 1p36 duplication. Appl Clin Genet (2016) 9:1–4. doi: 10.2147/TACG.S90713
16. Walton SF, Pizzutto S, Slender A, Viberg L, Holt D, Hales BJ, et al. Increased allergic immune response to Sarcoptes scabiei antigens in crusted versus ordinary scabies. Clin Vaccine Immunol (2010) 17:1428–38. doi: 10.1128/CVI.00195-10
17. Mounsey KE, Murray HC, Bielefeldt-Ohmann H, Pasay C, Holt DC, Currie BJ, et al. Prospective study in a porcine model of Sarcoptes scabiei indicates the association of Th2 and Th17 pathways with the clinical severity of scabies. PloS Negl Trop Dis (2015) 9:e0003498. doi: 10.1371/journal.pntd.0003498
Keywords: scabies, Sarcoptes scabiei, inflammatory responses, host-parasite interactions, immunology
Citation: Mounsey KE (2023) Commentary: Transcriptome analysis of host inflammatory responses to the ectoparasitic mite Sarcoptes scabiei var. hominis. Front. Immunol. 14:1128688. doi: 10.3389/fimmu.2023.1128688
Received: 21 December 2022; Accepted: 06 February 2023;
Published: 15 February 2023.
Edited by:
Dario S. Zamboni, University of São Paulo, BrazilReviewed by:
Walderez Ornelas Dutra, Federal University of Minas Gerais, BrazilCopyright © 2023 Mounsey. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Kate E. Mounsey, kmounsey@usc.edu.au